Alongside our commercial and financial responsibilities, we recognize our wider responsibilities to society.
To make sure we can deliver our commitments to the patients, stakeholders and shareholders who rely on us, we are focused on improving the way we do business. Whether that is operating with transparency in everything we do, and listening to the views of all of the people involved in healthcare decisions.
To ensure we do this, our business operates to the Anglo Laboratory Research & Pharmaceutical Company Code of Conduct, as well as the regulations that govern the pharmaceutical industry globally and in the UK.
TRANSPARENCY
We know that transparency is essential to building and maintaining confidence in us and in our medicines. We want people to know, and understand, what we do and how we do i
Our business is regulated by the Association of the British Pharmaceutical Industry (ABPI) Code of Practice for the Pharmaceutical Industry which has detailed requirements to ensure its member companies operate in a responsible, ethical and professional manner. The Code includes requirements for how we may work with healthcare professionals, healthcare organisations and patient organisations and in recent years it has introduced new requirements for greater transparency in these areas.
We strongly support the work the European Federation of Pharmaceutical Industries and Associations (EFPIA) and ABPI have done to move towards greater transparency across the pharmaceutical industry.
WORKING WITH HEALTHCARE PROFESSIONALS, HEALTHCARE ORGANISATIONS AND PATIENT ORGANISATIONS
Working with healthcare professionals (HCPs), healthcare organisations (HCOs) and patient organisations allows us to share knowledge and in turn, helps us to better prevent, treat and potentially cure diseases and improve the quality of people’s lives.
These working relationships mean we can use our knowledge to help healthcare professionals get the best out of our medicines, allow our scientists to monitor the impact of our treatments and to work in partnership with the NHS to deliver more effective and efficient care.
It is important the public feels confident our relationships are appropriate and beneficial. We’re committed to transparency, and we hope that the healthcare professionals we work with feel the same. That is why Bedfordshire Biotech has taken the decision to only work in future with those who are happy to share information about our work together in the public domain.
Financial support for healthcare professionals
We think HCPs should be appropriately paid for the time they invest and expertise they offer, but it is right to continually review how this works in practice.
Financial or other support for healthcare organisations
Bedfordshire Biotech Limited has close working relationships with healthcare organisations and there are occasions when we may offer financial or other types of support to the NHS and other organisations.
Financial or other support for patient organisations
Bedfordshire Biotech Limited exists to discover and develop medicines that save and improve the lives of patients. To succeed, we need to have a true understanding of what patients need so that we can do our best to achieve better outcomes for them.
To do this, we work with patient experts who have expertise in a whole range of areas. At times, we provide financial aid such as charitable donations or sponsorships to support the organisations’ work, paying for expert advice and providing non-financial benefits or ‘benefits in kind’ when we partner or collaborate on projects.
RESEARCH AND DEVELOPMENT
The pharmaceutical industry developed 90% of medicines available today, however we know we can’t do it completely on our own. While our scientists are working hard to develop and discover medicines in our own laboratories, they also work with third parties from across life sciences.
As part of the ABPI’s move towards greater transparency, pharmaceutical companies now share data on how much they have spent on conducting research and development activities in the UK.
CODES OF CONDUCT
At Bedfordshire Biotech Limited, integrity means more than just complying with the law. It is one of our core values. It reflects who we are as a company and as individuals.
We believe we are all responsible for understanding the important legal and ethical issues affecting our business. By ensuring that we act with integrity at all times we are able to earn the trust and respect of the people we serve.
Our commitment to doing the right thing means that it is the responsibility of every Bedfordshire Biotech Limited colleague around the world to keep to the company policies on business conduct and the laws that govern our industry.
Every colleague across the world receives the “Blue Book”, a summary of Bedfordshire Biotech Limited Policies on Business Conduct. The book is an up to date guide to the company’s compliance structure, applicable laws, key policies and procedures that help us to do the right thing and act with integrity at all times.
As an industry, we are also subject to regulation by a number of government and industry bodies. They set the standards and processes which ensure that medicines are effective, safe and marketed appropriately.
ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY (ABPI)
The ABPI is the recognised body representing the pharmaceutical industry in the UK. Through its Code of Practice, it sets the standards for the promotion of prescription medicines to health professionals and for information made available to the public about prescription-only medicines.
Advertising or promoting prescription-only medicines to the public is prohibited under the ABPI Code and UK law. However, we are allowed to promote medicines to healthcare professionals (HCPs) and other relevant decision makers.
As well as promotional material, the Code covers meetings, the provision of medical and educational goods and services, joint working with the NHS, and the use of HCPs as consultants, as well as among many other areas.
The ABPI Medical Representatives Examination is taken by all our sales representatives who call on doctors, dentists, other UK prescribers and other relevant decision makers. It is a requirement of the ABPI Code of Practice that the Exam is sat during the first year of employment in such a role and must be passed within two years.
THE PRESCRIPTION MEDICINES CODE OF PRACTICE AUTHORITY (PMCPA)
The PMCPA is a self-regulatory body which was established by the ABPI to independently operate the Code of Practice. It is responsible for investigating any complaints about the activities of pharmaceutical companies.
PROPRIETARY ASSOCIATION OF GREAT BRITAIN (PAGB) CODE OF PRACTICE
The PAGB is the UK trade association which represents the manufacturers of branded over-the-counter medicines, self-care medical devices and food supplements. Through its Code of Practice, it ensures balanced and responsible marketing of self care products, maintaining a fair and positive regulatory environment that encourages product innovation, and promotes the contribution that self-medication can make to people’s health at no cost to the NHS.
ENVIRONMENT, HEALTH AND SAFETY
Bedfordshire Biotech Limited believes that a sustainable future is essential to ensuring the health and well-being of colleagues and the communities it touches. Our Environmental, Health and Safety (EHS) performance goes above and beyond compliance with regulatory and legal requirements.
I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.